Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason Haas files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Octavio Espinoza - $13.03M of LGND open-market activity in the last 12 months
- Andrew Reardon - $7.34M of LGND open-market activity in the last 12 months
- Jason Aryeh - $2.96M of LGND open-market activity in the last 12 months
- John L. Lamattina - $2.44M of LGND open-market activity in the last 12 months
- Nancy Ryan Gray - $1.35M of LGND open-market activity in the last 12 months
- John W. Kozarich - $1.18M of LGND open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jason Haas?
Jason Haas is a corporate insider, tracked as Director of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jason Haas submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jason Haas been buying or selling stock?
Recorded transactions: 1 open-market purchase ($20K) and 4 open-market sales ($3.77M) across all tracked filings.
Where can I see all of Jason Haas's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jason Haas and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
